| Literature DB >> 18611712 |
M Sato1, H Tsuchiya, T Miyazaki, S Fujiwara, R Yamaguchi, H Kureshiro, M Iinuma.
Abstract
Anti-candidal hydroxychalcone, 2,4,2'-trihydroxy-5'-methylchalcone (THMC), was investigated for its antibacterial activity against methicillin-resistant Staphylococcus aureus (MRSA). THMC showed the minimum inhibitory concentrations of 25.0-50.0 mug/ml against tested 20 strains, at which the effect was based on a bacteriostatic action. THMC of 25.0 mug/ml completely inhibited the incorporation of radio-labelled thymidine and uridine into MRSA cells. In combination with antibiotics, the fractional inhibitory concentration indices were 0.47 for gentamicin and 0.79 for vancomycin, indicating that THMC acts synergistically with these agents. THMC would be a potent therapeutic agent for MRSA infections.Entities:
Year: 1996 PMID： 18611712 DOI： 10.1016/0924-8579(95)00065-8
Source DB: PubMed Journal: Int J Antimicrob Agents ISSN： 0924-8579 Impact factor: 5.283